Rectal artesunate as pre-referral treatment for severe malaria in sub-Saharan Africa: still a long way to go
Open Access
- 21 December 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Global Health
- Vol. 11 (2) , e181-e182
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Acceptability of pre-referral rectal artesunate for severe malaria in children under 5 years by health workers and caregivers in the Democratic Republic of the Congo, Nigeria and UgandaMalaria Journal, 2022
- Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational studyBMC Medicine, 2022
- Stopping prereferral rectal artesunate — a grave errorBMJ Global Health, 2022
- Prereferral rectal artesunate and referral completion among children with suspected severe malaria in the Democratic Republic of the Congo, Nigeria and UgandaBMJ Global Health, 2022
- Readiness of the Kenyan public health sector to provide pre-referral care for severe paediatric malariaTropical Medicine & International Health, 2022
- Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatmentMalaria Journal, 2010
- Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunateMalaria Journal, 2010
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2009